IL-25:II型炎症通路创新靶点 剑指百亿美元特应性皮炎市场

长江证券
11 Jun

IL-25l:II型炎症通路 新靶点,与多种皮肤疾病病理有关白细胞介素-17E(即IL-25)是IL-17 细胞因子家族的成员,该家族包括IL-17A 至IL-17F,在宿主防御反应和炎症疾病中发挥关键作用。IL-25 被认为是一种II 型细胞因子,能够诱导IL-4、IL-5 和IL-13 的产生,进而抑制辅助性T 细胞 (Th) 17 的分化。IL-25 已被证实能以细胞环境依赖的方式激活多个...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10